|
|
Volumn 108, Issue 11, 2001, Pages 1319-1325
|
|
The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia
|
|
Author keywords
Cholinesterase inhibitors; Cognitive; Dementia; Motor; Parkinson's
|
|
Indexed keywords
AMANTADINE;
ANTIPARKINSON AGENT;
BROMOCRIPTINE;
CHOLINESTERASE INHIBITOR;
CLOZAPINE;
DONEPEZIL;
LEVODOPA;
PERGOLIDE;
SELEGILINE;
TACRINE;
ADD ON THERAPY;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
COGNITION;
CONTROLLED STUDY;
DAILY LIFE ACTIVITY;
DEMENTIA;
DRUG EFFECT;
DRUG INDUCED DISEASE;
FEMALE;
HUMAN;
MALE;
MOTOR ACTIVITY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
ACTIVITIES OF DAILY LIVING;
AGED;
ANALYSIS OF VARIANCE;
CHOLINESTERASE INHIBITORS;
COGNITION;
DEMENTIA;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MOTOR SKILLS;
NEUROPSYCHOLOGICAL TESTS;
PARKINSON DISEASE;
PATIENTS;
|
|
EID: 0035207628
PISSN: 03009564
EISSN: None
Source Type: Journal
DOI: 10.1007/s007020100008 Document Type: Article |
|
Times cited : (89)
|
|
References (22)
|
